Ive seen estimates around tens of billions of lost revenue from US biotech companies every year.
You mean when it has the potential to save millions of lives vs pay less in pharma CEO bonuses?
> Ive seen estimates around tens of billions of lost revenue from US biotech companies every year.
Cry me a river.
Yet because of their incredibly weak IP protections many drug companies are reluctant to sell there. Hundreds of medicines simply aren't available despite being released a decade earlier and Indians in need have to pay European prices for access to modern pharmaceuticals. It's entirely destroyed any chance for local r&d too.
It's not a net benefit.
I'm all for sticking it to the Man and especially criticising big pharma but suggest reconsidering your viewpoint here.